Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ·Healthcare·Biotechnology
$37.99
-1.63%
Mkt Cap $4.01B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (21 analysts)
$86.60
Range $67.00 – $105.00
Implied Upside
+128.0%
Consensus $86.60 vs current $37.99